Paying users zone. Data is covered by 
.
Get to AbbVie Inc. for $19.99, or
get to entire website for at least 3 months from $49.99.
AbbVie Inc. (ABBV)
DuPont Analysis: Decomposition of ROE
Difficulty: Beginner
Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.
Two-Component Disaggregation of ROE
AbbVie Inc., decomposition of ROE
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.
Three-Component Disaggregation of ROE
AbbVie Inc., decomposition of ROE
| ROE | = | Net Profit Margin | × | Asset Turnover | × | Leverage | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|||
| Dec 31, 2017 | |
|
|
|
|||
| Dec 31, 2016 | |
|
|
|
|||
| Dec 31, 2015 | |
|
|
|
|||
| Dec 31, 2014 | |
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.
Five-Component Disaggregation of ROE
AbbVie Inc., decomposition of ROE
| ROE | = | Tax Burden | × | Interest Burden | × | EBIT Margin | × | Asset Turnover | × | Leverage | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|
|
|||||
| Dec 31, 2017 | |
|
|
|
|
|
|||||
| Dec 31, 2016 | |
|
|
|
|
|
|||||
| Dec 31, 2015 | |
|
|
|
|
|
|||||
| Dec 31, 2014 | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.
Two-Way Decomposition of ROA
AbbVie Inc., decomposition of ROA
| ROA | = | Net Profit Margin | × | Asset Turnover | |
|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
||
| Dec 31, 2017 | |
|
|
||
| Dec 31, 2016 | |
|
|
||
| Dec 31, 2015 | |
|
|
||
| Dec 31, 2014 | |
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the increase in Return on Assets (ROA) over 2018 year is the increase in Asset Turnover.
Four-Way Decomposition of ROA
AbbVie Inc., decomposition of ROA
| ROA | = | Tax Burden | × | Interest Burden | × | EBIT Margin | × | Asset Turnover | |
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|
||||
| Dec 31, 2017 | |
|
|
|
|
||||
| Dec 31, 2016 | |
|
|
|
|
||||
| Dec 31, 2015 | |
|
|
|
|
||||
| Dec 31, 2014 | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the increase in Return on Assets (ROA) over 2018 year is the increase in effect of taxes measured by Tax Burden.
Decomposition of Net Profit Margin
AbbVie Inc., decomposition of Net Profit Margin
| Net Profit Margin | = | Tax Burden | × | Interest Burden | × | EBIT Margin | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|||
| Dec 31, 2017 | |
|
|
|
|||
| Dec 31, 2016 | |
|
|
|
|||
| Dec 31, 2015 | |
|
|
|
|||
| Dec 31, 2014 | |
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).
The primary reason for the decrease in Net Profit Margin over 2018 year is the decrease in operating profitability measured by EBIT Margin.